2.5199  0.04 (1.61%)		07-26 16:00
Open: 2.58 High: 2.58 Volume: 6,262		Pre. Close: 2.48 Low: 2.47 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	3.57	1-year :	4.17
Resists	First :	3.05	Second :	3.57
Pivot price	2.34
Supports	First :	2.28	Second :	1.79
MAs	MA(5) :	2.4	MA(20) :	2.43
	MA(100) :	3.25	MA(250) :	3.16
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	50.7	D(3) :	50
RSI	RSI(14): 48.6
52-week	High :	8.1	Low :	1.13

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IMCC ] has closed below upper band by 27.2%. Bollinger Bands are 64% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.58 - 2.59	2.59 - 2.6
Low:	2.44 - 2.46	2.46 - 2.47
Close:	2.5 - 2.52	2.52 - 2.54

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Fri, 12 Jul 2024
IM Cannabis shares begin trading on 6:1 consolidated basis - Investing.com

Fri, 12 Jul 2024
IM Cannabis Corp. Initiates Consolidated Stock Trading - TipRanks

Fri, 12 Jul 2024
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis - PR Newswire

Wed, 10 Jul 2024
IM Cannabis Stock to Reverse Split on Friday, July 12th (NASDAQ:IMCC) - Defense World

Tue, 09 Jul 2024
CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC) - Newsfile

Wed, 08 May 2024
IM Cannabis Reports First Quarter Financial Results - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	2 (M)
Shares Float	2 (M)
Held by Insiders	35.8 (%)
Held by Institutions	8 (%)
Shares Short	6 (K)
Shares Short P.Month	27 (K)

EPS	-4.87
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.26
Profit Margin	-30.1 %
Operating Margin	-23.9 %
Return on Assets (ttm)	-15 %
Return on Equity (ttm)	-93.6 %
Qtrly Rev. Growth	-3.8 %
Gross Profit (p.s.)	0
Sales Per Share	21.67
EBITDA (p.s.)	-4.2
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	3 (M)

PE Ratio	-0.52
PEG Ratio	0
Price to Book value	0.59
Price to Sales	0.11
Price to Cash Flow	-2.13

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.